LONDON--(BUSINESS WIRE)--Technavio has been monitoring the dengue vaccine market and it is poised to grow by $ 630.65 million during 2020-2024, progressing at a CAGR of over 26% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. We offer $1000 worth of FREE customization
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Avida-Biotech, Emergex Vaccines Holding Ltd., GeneOne Life Science Inc., Imutex Ltd., KM Biologics Co. Ltd., Medigen Biotechnology Corp., Panacea Biotec Ltd, Sanofi, Takeda Pharmaceutical Co. Ltd., and VLP Therapeutics LLC are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Rapid growth in disease prevalence has been instrumental in driving the growth of the market. However, regulatory hurdles in vaccine penetration might hamper market growth.
Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Download a Free Sample Report on COVID-19 Impacts
Dengue Vaccine Market 2020-2024: Segmentation
Dengue Vaccine Market is segmented as below:
-
End-User
- Government institutions
- Hospitals
- NGOs
-
Geography
- North America
- Asia
- Europe
- ROW
Dengue Vaccine Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The dengue vaccine market report covers the following areas:
- Dengue Vaccine Market Size
- Dengue Vaccine Market Trends
- Dengue Vaccine Market Industry Analysis
This study identifies ineffective dengue control measures as one of the prime reasons driving the dengue vaccine market growth during the next few years.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Dengue Vaccine Market 2020-2024: Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist dengue vaccine market growth during the next five years
- Estimation of the dengue vaccine market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the dengue vaccine market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of dengue vaccine market, vendors
Table of Contents:
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Customer Landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Explore Technavio
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
